Angiosarcoma Awareness Inc has provided a $25k grant to the Broad Institute in order to obtain and ship living tumor samples from angiosarcoma patients to the Cancer Cell Line Factory
July 2, 2021
Each cancer center may only see a small handful of patients with a given rare tumor a year, making the collection of living tissue samples—at the scale required to create laboratory cell […]
The Angiosarcoma Project in the News
September 30, 2018
The American Association for Cancer Research (AACR) issued the following press release focused on the Angiosarcoma Project, whose work is guided by Angiosarcoma Awareness, Inc.’s Vice President Dr. Corrie Painter. […]
New clinical trial is now recruiting in Boston
February 13, 2018
A new Phase II clinical trial targeting angiosarcoma is now recruiting patients at Boston’s Massachusetts General Hospital and the Dana-Farber Cancer Institute. For details on this and other available trials, […]
Presenting the We Will Prevail 5K!
January 30, 2018
After taking a year off for a strategic re-brand, we are excited to unveil the return of our community’s beloved 5K event, revamped for its 7th year, in its new […]
Unprecedented angiosarocma research opportunities
October 13, 2017
Because angiosarcoma is an exceedingly rare cancer, it has never been the focus of large scale scientific endeavors. However, patients are now able to participate in two research projects aimed […]
Announcing a new rare cancer collaboration
September 7, 2017
We are pleased to announce that Angiosarcoma Awareness, Inc. has entered into a unique year-long collaboration with a fellow rare cancer advocacy organization, TargetCancer Foundation (TCF). This partnership will leverage the strengths of […]
Join us for Raft 4 Life: August 25-27, 2017
August 11, 2017
“I knew I was making progress when Tory said to me, ‘I forgot I had cancer for an entire day’ with happy tears rolling down her cheeks. My heart was […]
The Angiosarcoma Project is now enrolling all angiosarcoma patients
March 18, 2017
ASCproject.org Please help us spread the word about the Angiosarcoma Project, which was recently launched as a collaboration between the Broad Institute of MIT and Harvard and the Dana-Farber Cancer […]